FLGT Q2 2020 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$447M

Q2 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$17M+105.0% YoY

Gross Profit

$10M55.3% margin

Operating Income

$3M15.3% margin

Net Income

$3M19.2% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

+122.7%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$5M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$96M

Total Liabilities

$9M

Stockholders' Equity

$87M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$8M	+105.0%
Gross Profit	$10M	$5M	+98.8%
Operating Income	$3M	$295,000	+794.9%
Net Income	$3M	$331,000	+903.3%

Geographic Segments

UNITED STATES

$16M93%

Other Countries

$798,0005%

CANADA

$329,0002%